Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Effects of exercise on inflammatory factors and IGF system in breast cancer survivors: a meta-analysis

BMC Women's Health volume 22, Article number: 507 (2022) Cite this article

Abstract

Background

At present, there are multiple hypotheses regarding the mechanisms underlying the effect of exercise on the postoperative inflammatory factors and the IGF system among breast cancer patients, especially. To determine the underlying mechanisms, prevent the recurrence of breast cancer and improve its prognosis, this paper will systematically evaluate the impact of exercise on inflammatory factors and the IGF system in breast cancer survivors.

Methods

The PubMed, Embase, Web of Science, CNKI, Wanfang and VIP (Chinese scientific and technical journals) databases were systematically searched until April 2021. The search terms included 'exercise', 'inflammatory factor', 'IGF system' and 'breast cancer'. A total of 1066 relevant articles were retrieved. The articles were screened according to inclusion and exclusion criteria, such as study population, intervention method and type of experiment, and 11 articles were ultimately included. All statistical results were analysed using STATA 14.0 and Rstudio 4.1.1.

Results

We found that exercise significantly reduced the level of IGF-1 (WMD, -19.947 ng/ml; 95% CI, -22.669 to -17.225; P = 0.000). Subgroup analysis showed that in the studies with an intervention period > 12 weeks, exercise significantly reduced IL-6 levels (WMD, -0.761 pg/ml; 95% CI, -1.369 to -0.153; p = 0.014), while in the studies with an intervention period ≤ 12 weeks, exercise significantly reduced CRP (WMD, -2.381 mg/L; 95% CI, -4.835 to 0.073, P = 0.001) and IL-10 levels (WMD, -7.141 pg/ml, 95% CI, -10.853 to -3.428; P = 0.000). In addition, aerobic exercise plus resistance training significantly reduced IL-6 levels (WMD, -1.474 pg/ml; 95% CI, -1.653 to -1.296; P = 0.000). The results of the sensitivity analysis showed that after excluding the studies with high heterogeneity, exercise significantly reduced the TNF-α levels in patients with breast cancer (WMD, -1.399 pg/ml; 95% CI, -1.718 to -1.080; P = 0.000).

Conclusion

Exercise reduces the postoperative levels of IGF-1, IL-6, CRP, IL-10 and TNF-α among patients with breast cancer, which may have a significant impact on inhibiting breast cancer recurrence and improving its prognosis. Future studies should examine the effects of different durations and types of exercise to develop individualized exercise prescriptions for breast cancer patients.

Peer Review reports

Background

Globally, breast cancer is the most common cancer as well as the most common cause of cancer-related death in women [1]. Therefore, how to reduce the recurrence rate of breast cancer and improve the survival rate of breast cancer patients is the main research focus. At present, several mechanisms have been proposed regarding the aetiology and progression of breast cancer [2], including inflammatory factors and the IGF system.

Inflammatory factors are synthesized by fibroblasts and endothelial cells, and they are dependent on the tumour microenvironment to regulate the survival, proliferation, differentiation, activation, migration and death of tumour cells [3]. The impact of chronic inflammation on tumorigenesis and the tumour microenvironment is widely recognized as playing a key role in the risk of cancer development, progression and recurrence [4]. The main inflammatory factors associated with tumours include interleukin 6 (IL-6), interleukin 10 (IL-10), interleukin 1β (IL-1β), tumour necrosis factor alpha (TNF-α) and C-reactive protein (CRP). Studies have shown that systemic inflammation – characterized by elevated levels of TNF-α, IL-6 and CRP – is associated with an increased risk of breast cancer progression and death [5,6,7,8]. In addition, elevated serum concentrations of IL-6, IL-10, IL-1β, and TNF-α are found in a variety of cancer types, including breast cancer [3, 9,10,11].

The insulin-like growth factor (IGF) system is made up of ligands, binding proteins and receptors that regulate important physiological and pathological processes. The ligands include the three major ligands, IGF-1, IGF-2 and insulin; the IGF receptors include the insulin receptor (IR), IGF-1R, IGF-2R and insulin-related receptor (IRR), and at least six circulating IGF binding proteins (IGFBPs) [12]. The biological activity of the IGF system depends on the binding of ligands to their cognate receptors; the cognate receptors of IGF-1, IGF-2 and insulin are IR, IGF-1R and IGF-2R, respectively. IGF-1R is expressed in a variety of human tissues, and its activation regulates cell survival, proliferation, differentiation and protein synthesis [13]. IGFs effectively bind to IGF-1R and activate pathways associated with cell proliferation, and the interaction between IGFs and IGF-1R promotes tumour cell growth and metastasis [14, 15]. The expression of insulin-like growth factor-1 (IGF-1) is higher in the sera of breast cancer patients than in those of benign tumour patients. Therefore, it has been suggested that elevated IGF-1 levels may predict tumour progression and metastasis [16]. IGFBPs can regulate IGF levels in serum and tissues, thereby promoting apoptosis of cancer cells. For example, IGFBP-3 is a highly relevant IGF-1 binding protein. IGFBP-3 can inhibit IGF-1 binding to IGF-1R (IGF-1 receptor) through competitive binding to IGF-1 [17, 18]. Studies have shown that elevated circulating levels of IGF-1 and reduced levels of IGFBP-3 are associated with an increased risk of premenopausal breast cancer [19,20,21].

Given the impact of inflammatory factors and the IGF system on breast cancer, improving the inflammatory status and IGF system in breast cancer survivors may be a new way to reduce the risk of breast cancer recurrence. Studies have shown that exercise can improve the tumour microenvironment in breast cancer patients. Physical activity is associated with lower levels of various proinflammatory cytokines [22, 23]. Epidemiological studies have shown that a highly physically active lifestyle is associated with lower circulating levels of TNF-α, IL-6 and CRP, independent of age, sex, body mass index or blood glucose [24]. High levels of physical activity are associated with 20%-60% lower levels of peripheral inflammatory mediators than a sedentary lifestyle [25]. In addition, exercise was also associated with levels of IGF-I and IGFBPs. [26, 27]. Physical activity reduces IGF-1 levels and increases IGFBP-3 levels [28], which in turn inhibits the IGF signalling pathway. In addition, there is an association between exercise and breast cancer-specific mortality and all-cause mortality. The risk of specific mortality and all-cause mortality is lower in breast cancer patients who participate in physical activity [29] [30,31,32]. There is growing evidence that exercise improves levels of inflammatory factors and the IGF system in breast cancer patients, reduces the risk of breast cancer recurrence and improves patient survival. However, the results among individual studies are inconsistent. Sprod et al. [33] found no significant changes in insulin-like growth factor binding protein-1 (IGFBP-1) and IGFPB-3 in 21 breast cancer survivors after a 12-week tai chi intervention. A meta-analysis also came to a different conclusion, with a significant reduction in IGFBP-3 levels following the exercise intervention [34]. In addition, another meta-analysis found that exercise interventions increased IL-6 and IL-10 levels [35]. However, these studies differed in terms of the time of the intervention and the mode of intervention, which may have contributed to the differences in the findings. The American College of Sports Medicine (ACSM) suggests that breast cancer patients should participate in at least 150 min of moderate or 75 min of vigorous aerobic exercise per week and strength training at least two days per week [36]. However, detailed information on exercise is still lacking, and further research is needed on which types or durations of interventions are most beneficial for breast cancer patients. Therefore, this meta-analysis will focus on the effects of exercise on IL-6, IL-10, IL-1β, CRP, TNF-α, IGF-1 and IGFBP-3 levels in breast cancer patients. The effects of different intervention durations and modalities on inflammatory factors and the IGF system will be further explored using subgroup analysis. Additionally, this meta-analysis aims to provide evidence regarding the effect of exercise on preventing the recurrence of breast cancer and improving its prognosis. Moreover, this study aims to provide a theoretical basis for the development of exercise interventions for breast cancer patients.

Methods

Search strategy

This meta-analysis was conducted in accordance with the PRISMA guidelines for evidence-based medicine. The PubMed, Embase, Web of Science, CNKI, Wanfang and VIP (China Science and Technology Journal) databases were systematically searched until April 2021. The search terms included "physical activity or exercise or sport or training" and "breast cancer or breast tumour or breast oncology" and "inflammatory or IL-6 or IL-10 or IL-1β or CRP or TNF-α or IGF or IGF-1 or IGFBP-3" (refer to supplemental 1). The protocol for this systematic review was registered on INPLASY (ID = INPLASY2021100101) and is available in full on the inplasy.com (https://doi.org/10.37766/inplasy00000000).

Eligibility criteria

All the retrieved literature was screened based on the inclusion and exclusion criteria. The screening criteria were as follows:

Inclusion criteria: (1) subjects: breast cancer survivors; (2) intervention measures: exercise intervention (including aerobic exercise, resistance exercise, resistance exercise combined with aerobic exercise, high-intensity interval training, etc.); (3) study content: effects of exercise group (physical activity) and control group on inflammatory factors or IGF system in patients with breast cancer; (4) intervention time: postoperative and 1 month to 5 years posttreatment; (5) study type: randomized controlled trial and include at least one blank group.

Exclusion criteria: (1) the intervention measures were not simple exercise but instead entailed exercise intervention combined with other therapies (such as exercise combined with diet or exercise combined with drugs); (2) only experimental design, there was no specific intervention process; (3) review study, duplicate publication and or unable to obtain the full text; and (4) the main research indicators were not consistent or the data were incomplete.

Data extraction

Two evaluators independently carried out retrieval and screening and then checked and compared the results. If there were any differences, they were decided by a third party. The extracted data included basic information (title, original study author, year of publication, country), basic characteristics of the subjects (sample size, mean age, sex, cancer stage, etc.), characteristics of the exercise intervention (exercise type, exercise frequency, exercise time, intensity, etc.), characteristics of the control group (routine treatment, placebo control, etc.) and the outcome indicators (the changes in indicators before and after intervention, P value and/or CI).

Risk of bias assessment

The Cochrane manual evaluation standard (version 5.0.2) was used to comprehensively evaluate the literature quality and objectively evaluate whether there were methodological errors and subjective biases. In summary, the risk of bias was assessed in the following six domains: (1) random sequence generation; (2) allocation concealment; (3) blinding; (4) incomplete outcome data; (5) selective outcome reporting; and (6) other sources of bias. The above criteria were used to evaluate the quality of the article, and the results were judged as "low risk", "high risk" or "unclear risk".

Outcome indicators

The outcome indicators included the levels of IL-6, IL-10, IL-1β, CRP, TNF-α, IGF-1 and IGFBP-3 in each group.

Statistical analysis

Stata 14.0 and R Studio 4.1.1 software [37] were used to perform a meta-analysis of the differences between endpoint and baseline indicators (formula: SDchange = √SD12 + SD22-(2*R*SD1*SD2), where R = 0.5). The extracted data were all continuous variables, and the individual test units were converted. Since the study of Karimi et al. [38] only mentioned endpoint indicators, we combined their postintervention data with differential data from other studies, in accordance with previous research [39]. The mean ± SD was chosen as the standard scale of effect in the article, and the statistics were expressed as weighted mean differences (WMDs) with 95% confidence intervals (CIs). P < 0.05 was considered to indicate a statistically significant difference. The I2 value was used to assess heterogeneity analysis among studies. When I2 = 0, no heterogeneity was observed among studies, and a fixed effects model was used; when I2 ≥ 50%, heterogeneity among studies was observed, and a random effects model was used. When there was heterogeneity between studies, subgroup analysis was used to analyse the sources of heterogeneity, such as grouping different intervention periods and types for the computational analysis of I2 values. In addition, to increase the credibility of the meta-analysis, sensitivity analysis was conducted to analyse whether there was a significant effect of any individual article on the pooled results.

Result

Article search results

After searching by subject terms and excluding duplicates, 1066 relevant articles were retrieved. After reading the titles, 364 articles remained. In addition, 289 articles were manually excluded after screening the abstracts, leaving 75 articles. A total of 17 articles met the criteria after reading the full text, of which 6 articles did not mention specific data. Therefore, 11 articles were ultimately included. A flow diagram for study selection is presented in Fig. 1.

Fig. 1
figure 1

Studies selection flow diagram

Full size image

Characteristics of the selected studies

Table 1 summarizes the details of the 11 included articles. In brief, 11 articles were reported from 10 RCTs. Of the 10 trials, 8 studies were 2-arm randomized controlled trials [40] with exercise groups and control groups; one study was a 3-arm randomized controlled trial including two exercise groups (high-intensity interval exercise plus resistance exercise, high-intensity interval exercise plus aerobic exercise) and control groups, which were analysed separately in the text; another study was a 4-arm randomized controlled trial including an exercise group, a ginger-taking group, the taking ginger plus exercise group and the placebo group, and then we extracted data only from the exercise and placebo groups. Among the 11 articles, nine studies examined IL-6 [33, 40,41,42,43,44,45,46,47], five studies examined CRP [38, 42, 44,45,46], five studies examined TNF-α [41,42,43, 45, 47], four studies examined IL-10 [38, 40, 41, 43], three studies examined IGF-1 [33, 45, 48] and IGFBP-3 [33, 45, 48], and 1 study examined IL-1β [41] (not analysed). The number of individuals in each study ranged from 16 to 240, with a total number of 696 individuals. The intervention types included aerobic, resistance training, aerobic plus resistance training, yoga, water-based exercise, HIIT plus aerobic exercise, HIIT plus resistance training, and tai chi. The intervention settings included supervised, home-based or mixed. The exercise intensity included moderate, vigorous, or increasing. The exercise frequency ranged from 1 session per week to 5 sessions per week. The intervention period ranged from 8 to 24 weeks, and the exercise duration ranged from 30–90 min.

Table 1 Characteristics of the selected studies
Full size table

Methodological quality of selected studies

All 10 randomized controlled trials mentioned randomization. Only 2 studies mentioned the method of randomization. Three studies mentioned allocation concealment. Only one study implemented blinding; because the interventions were exercise, blinding was difficult to implement. Seven studies mentioned participant dropout or loss to follow-up. The methodological quality of the studies is shown in Figs. 2 and 3.

Fig. 2
figure 2

Risk of bias

Full size image
Fig. 3
figure 3

Risk of bias domains. Study (Top down): Irwin, etc.(2009,2012); Lisa, etc.(2011); Gomez, etc.(2011); Rogers, etc.(2012);Bower, etc.(2013); Karimi, etc. [38]; Christina, etc. (2017); Christina, etc. (2018); Kim, etc. (2019); Anouk E, etc. (2020)

Full size image

Results of meta-analyses

The effect of exercise on IL-6 levels

Nine studies analysed the effect of exercise on IL-6 levels across a total of 318 participants (Fig. 4). A random effects model was used due to the high heterogeneity among the pooled studies (I2 = 88.2%). The analysis showed a trend towards a decrease in IL-6 levels following the exercise intervention, but there was no statistically significant difference in IL-6 levels between the exercise group and the control group (WMD, -0.479 pg/ml; 95% CI, -1.107 to 0.149, p = 0.195).

Fig. 4
figure 4

Forest plot of comparison for IL-6 levels. Anouk E, etc. (2020)* RT + HIIT group; Anouk E, etc. (2020)#AT + HIIT group

Full size image

The effect of exercise on CRP levels

Five studies reported the effects of exercise on CRP levels (Fig. 5). A random effects model was used due to the high heterogeneity among the pooled studies (I2 = 99.0%). The results showed a trend towards a decrease in CRP levels after the exercise intervention, but the effect of exercise on CRP levels was not statistically significant (WMD, -2.381 mg/L; 95% CI, -4.835 to 0.073; P = 0.057).

Fig. 5
figure 5

Forest plot of comparison for CRP levels. Karimi, etc. [38]: endpoint indicators

Full size image

The effect of exercise on TNF-α levels

Five studies reported the effect of exercise on TNF-α levels (Fig. 6). A random effects model was used due to the high heterogeneity among the pooled studies (I2 = 92.3%). The results showed a trend towards a decrease in TNF-α levels after exercise intervention, but the effect of exercise on TNF-α levels was not statistically significant (WMD, -1.399 pg/ml; 95% CI, -1.718 to -1.080; P = 0.245).

Fig. 6
figure 6

Forest plot of comparison for TNF-α levels

Full size image

The effect of exercise on IL-10 levels

Four studies analysed the effect of exercise on IL-10 levels (Fig. 7) across a total of 150 participants. A random effects model was used due to the high heterogeneity among the pooled studies (I2 = 78.5%). The results showed a trend towards a decrease in IL-10 levels after exercise intervention, but the effect of exercise on IL-10 levels was not statistically significant (WMD, -0.029 pg/ml; 95% CI, -0.367 to 0.309; P = 0.866).

Fig. 7
figure 7

Forest plot of comparison for IL-10 levels. Abbreviations: Karimi et al. [38] are endpoint indicators; Anouk E, etc. (2020)* RT + HIIT group; Anouk E, etc. (2020)#AT + HIIT group

Full size image

The effect of exercise on IGF-1 levels

Three studies reported the effect of exercise on IGF-1 levels (Fig. 8). A fixed effects model was used due to the lack of statistical heterogeneity among the pooled studies (I2 = 0.0%). I2 was 0.0%, and there was no statistical heterogeneity, so a fixed effect model was used. The results showed a significant effect of exercise on IGF-1 levels (WMD, -19.947 ng/ml; 95% CI, -22.669 to -17.225; P = 0.000).

Fig. 8
figure 8

Forest plot of comparison for IGF-1 levels

Full size image

The effect of exercise on IGFBP-3 levels

Three studies reported the effect of exercise on IGFBP-3 levels (Fig. 9). A random effects model was used due to the high heterogeneity among the pooled studies (I2 = 95.1%). I2 was 95.1%, and there was a high degree of heterogeneity between studies, so a random effects model was used. There was an increasing trend in IGFBP-3 levels after the exercise intervention, but the effect of exercise on IGFBP-3 levels was not significant (WMD, 4.501 ng/ml; 95% CI, -1.099 to 10.101; P = 0.115).

Fig. 9
figure 9

Forest plot of comparison for IGFBP-3 levels

Full size image

Subgroup analysis

Considering the large differences in the intervention period among all studies, we grouped them according to the intervention periods: > 12 weeks and ≤ 12 weeks. To analyse the heterogeneity of the included studies, we performed subgroup analyses for some of the studies, as shown in Table 2. (1) Subgroup analysis of the effect of exercise on IL-6 levels: A total of 9 studies examining IL-6 levels were included, including 5 studies with an intervention period ≤ 12 weeks and 4 studies with an intervention period > 12 weeks. The results of the subgroup analysis showed that the effect of exercise on IL-6 levels was significant in studies with an exercise intervention period > 12 weeks (WMD, -0.761 pg/ml; 95% CI, -1.369 to -0.153; p = 0.014), while in studies with an exercise intervention period ≤ 12 weeks, there was no significant effect of exercise on IL-6 levels (WMD, 0.615 pg/ml; 95% CI, -0.763 to 1.993; p = 0.382). (2) Subgroup analysis of the effect of exercise on CRP and IL-10 levels: In studies with an intervention period ≤ 12 weeks, exercise had significant effects on CRP (WMD, -2.381 mg/L; 95% CI, -4.835 to 0.073, p = 0.001) and IL-10 levels (WMD, -7.141 pg/ml; 95% CI, -10.853 to -3.428; P = 0.000).

Table 2 Subgroup analysis of different intervention periods
Full size table

In addition, we performed a subgroup analysis based on intervention type, but due to the number of articles for each outcome, we only examined studies that reported IL-6 levels. The results of the subgroup analysis are shown in Table 3. Among the studies that reported IL-6 levels, there were 4 studies that used aerobic plus resistance training, two studies that used Tai Chi and yoga, one study that used aerobic exercise, one study that used resistance exercise, one study that used high-intensity interval exercise plus resistance exercise, and one study that used high-intensity interval exercise plus aerobic exercise. Subgroup analyses showed that the effect of aerobic plus resistance exercise on IL-6 levels was significant (WMD, -1.474; 95% CI, -1.653 to -1.296; P = 0.000).

Table 3 Subgroup analysis of the effect of different intervention types on IL-6 levels
Full size table

Sensitivity analysis

Due to the small number of articles, we only performed sensitivity analyses on articles that examined IL-6, TNF-α and CRP levels. The results of the sensitivity analyses of the effects of exercise on IL-6 and CRP levels are shown in Figs. 10 and 11, respectively. The results were found to be relatively stable and reliable. However, sensitivity analysis of the 5 studies that examined TNF-α levels (Table 4) revealed a high degree of heterogeneity in the study by Jones et al. This study was excluded, and meta-analysis was performed again (Fig. 12). There was no heterogeneity (I2 = 0.0%), and thus, a fixed effects model was used. The results showed a significant difference in TNF-α levels between the exercise group and the control group (WMD, -1.399 pg/ml; 95% CI, -1.718 to -1.080; P = 0.000).

Fig. 10
figure 10

Sensitivity analysis of IL-6 levels. Anouk E, etc. (2020)* RT + HIIT group; Anouk E, etc. (2020)# AT + HIIT group

Full size image
Fig. 11
figure 11

Sensitivity analysis of CRP levels

Full size image
Table 4 Sensitivity analysis of CRP
Full size table
Fig. 12
figure 12

Forest plot of comparison for TNF-α levels after excluding highly heterogeneous studies

Full size image

Publication bias

The Begg (p = 0.602) test and Egger (p = 0.068) test showed no risk of publication bias, and we did not perform a funnel analysis because there were fewer than 10 references.

Discussion

Most existing studies on the effects of exercise on inflammatory factors and IGF systems in breast cancer survivors examine IL-6, IL-10, IL-1β, TNF-α, CRP, IGF-1, and IGFBP-3 levels. Previous meta-analyses have quantified the effects of exercise on the levels of inflammatory factors and IGF systems [49, 50], but no quantitative analysis was performed based on exercise period and type. The current study explores the effects of different intervention periods and different intervention types on the combined effects of outcomes. Further quantitative evaluation of the effects of exercise on inflammatory factors and IGF systems will provide a basis for more individualized studies.

Our meta-analysis showed that exercise intervention significantly reduced IGF-1 levels in breast cancer survivors, and further subgroup analyses showed significant improvements in IL-6 levels in the exercise group compared with the control group when the intervention period was longer than 12 weeks and a significant effect of exercise on CRP and IL-10 levels when the intervention period was less than or equal to 12 weeks. In addition, aerobic exercise plus resistance training significantly reduced IL-6 levels. Sensitivity analysis showed that exercise had a significant effect on TNF-α levels in breast cancer survivors after excluding highly heterogeneous studies.

Inflammatory factors

Tumour-associated inflammation is one of the hallmarks of breast cancer [51]. Studies have shown that exercise is associated with lower levels of various proinflammatory cytokines [22, 23]. A study on breast cancer patients found a negative association between exercise and IL-6 levels; other meta-analyses have also shown a significant decrease in IL-6 and CRP levels after exercise intervention [52]. However, in our meta-analysis, we only found that exercise intervention significantly reduced TNF-α levels after excluding highly heterogeneous studies; we did not find a significant effect of exercise on any other inflammatory factors. Further subgroup analyses showed that exercise significantly reduced IL-6 levels when the intervention period was > 12 weeks, but exercise had a nonsignificant effect on IL-6 levels when the intervention period was ≤ 12 weeks. In contrast, exercise significantly reduced CRP and IL-10 levels when the intervention period was ≤ 12 weeks. This suggests a possible effect of different intervention periods on the experimental results. There was significant heterogeneity in the results of the intervention period subgroup analysis (91.3%, 99.5%, 98.0%, 60.7%), suggesting that the effect of exercise on IL-6, CRP, TNF-α, and IL-10 levels in breast cancer patients with different intervention periods is likely to be a source of heterogeneity in the included studies. Therefore, we hypothesized that there may be a complex correlation between the period of intervention and changes in inflammatory factors. A study analysis [52] concluded that for the elderly population, short-term intervention training hardly leads to significant changes in the organism at the level of indicators. However, long-term exercise may not show changes in inflammatory markers, as older adults are susceptible to other uncontrolled environmental factors, which in turn affect the levels of inflammatory factors. In addition, we found that aerobic plus resistance training significantly reduced IL-6 levels. Previous studies [53, 54] have identified the benefits of aerobic plus resistance training, which improves the overall functional capacity of breast cancer patients. As a result, a growing number of studies have now evolved from just one type of exercise to a more complex exercise prescription of aerobic exercise combined with resistance training. However, we included too few studies on other inflammatory factors to analyse the effects of other intervention types on outcomes. More studies should be included in the future to analyse the effects of the exercise intervention period and exercise type on inflammatory markers in breast cancer patients to develop the optimal intervention.

IGF system

The IGF system is an important mechanism in breast cancer pathogenesis. The IGF signalling system plays an important role in breast cancer development and progression [55, 56]. Therefore, targeting the IGF system is a better option. Studies have shown that exercise can reduce IGF-1 levels and increase IGFBP levels [28]. Exercise is thought to cause physiological changes in systemic IGF ligand and binding protein bioavailability, which may indirectly affect IGF-1R signalling [57]. In our meta-analysis, we included three studies that examined IGF-1 levels, and all three studies reported that exercise significantly decreased IGF-1 levels. A meta-analysis [50] involving 7 studies of breast cancer patients also found a trend towards decreased IGF-I levels after exercise, but this was not statistically significant (WMD, -5.23 ng/mL; 95% CI, 13.00 to 2.53; p = 0.19). However, this meta-analysis found no significant effect of exercise on IGFBP-3 levels (WMD, 0.01; 95% CI, -0.96 to 0.98; p = 0.99). This is similar to the findings of our study, which found a nonsignificant trend of improved IGFBP-3 levels after exercise. Among the included studies that examined levels IGFBP-3 that we included, two of them [42, 46] reported elevated IGFBP-3 levels after exercise, while another 6-month aerobic exercise study [49] found a significant reduction of 4.1% (p = 0.006) in IGFBP-3 levels in the intervention group compared to the control group. The results showed a significant discrete pattern, which may be related to intervention type. In a 6-month study [58] of prostate cancer patients with aerobic or resistance exercise programs, a significant increase in serum IGFBP-3 levels (12.1%; P ≤ 0.05) was observed in the resistance exercise group, while IGFBP-3 levels were reduced by 23.7% (P ≤ 0.05) in the aerobic exercise group. However, this may be only a conjecture, as baseline levels of IGFBP-3 were significantly higher in the aerobic exercise group than in the resistance training group in this study, and participants in this study also differed significantly from those in our study. Therefore, more studies should be included in the future meta-analyses.

The meta-analysis had a small number of included studies and included only English and Chinese studies, which may have led to selection bias. Second, this study did not adjust for potential confounders such as age, BMI, and sex, which may have a potential effect on the study results. Third, due to the small number of included studies and the lack of available data, the subgroup analysis only examined the effect of different exercise periods and types on certain outcomes. A comprehensive subgroup analysis of the characteristics of exercise intervention is warranted for future studies.

Conclusion

This study affirms that exercise positively affects inflammatory factors and the IGF system in breast cancer survivors. Exercise is feasible for breast cancer survivors. However, the most beneficial exercise period, type and intensity for improving inflammatory factors and IGF systems in breast cancer patients are not clear. Future studies should include more randomized controlled trials to analyse the appropriate exercise intervention for breast cancer patients to improve inflammatory factors and IGF systems and to provide a basis for developing individualized exercise prescriptions for breast cancer patients.

Availability of data and materials

All data generated or analyzed during this study are included in this published article [and its supplementary information files].

Abbreviations

AT:

Aerobic training

RT:

Resistance training

HE:

Health education

GS:

Ginger supplement

SST:

Standard support therapy

UC:

Usual care

TCC:

Tai chi chuan

References

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917.

    Article  CAS  Google Scholar 

  2. Cavalieri EL, Rogan EG. The etiology and prevention of breast cancer. Drug Discov Today Dis Mech. 2012;9(1–2):e55–69.

    Article  Google Scholar 

  3. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997;6(3):315–25.

    Article  CAS  Google Scholar 

  4. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7.

    Article  CAS  Google Scholar 

  5. Hartog H, Boezen HM, de Jong MM, Schaapveld M, Wesseling J, van der Graaf WT. Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer. Breast (Edinburgh, Scotland). 2013;22(6):1155–60.

    Article  CAS  Google Scholar 

  6. Duggan C, Wang CY, Neuhouser ML, Xiao L, Smith AW, Reding KW, Baumgartner RN, Baumgartner KB, Bernstein L, Ballard-Barbash R, et al. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer. 2013;132(5):1191–200.

    Article  CAS  Google Scholar 

  7. Coughlin SS, Smith SA. The Insulin-like Growth Factor Axis, Adipokines, Physical Activity, and Obesity in Relation to Breast Cancer Incidence and Recurrence. Cancer Clin Oncol. 2015;4(2):24–31.

    Google Scholar 

  8. Christopoulos PF, Msaouel P, Koutsilieris M. The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer. 2015;14:43.

    Article  Google Scholar 

  9. Lippitz BE. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol. 2013;14(6):e218-228.

    Article  CAS  Google Scholar 

  10. Machairiotis N, Vasilakaki S, Thomakos N. Inflammatory Mediators and Pain in Endometriosis: A Systematic Review. Biomedicines. 2021;9(1):54.

    Article  CAS  Google Scholar 

  11. Yarilina A, Park-Min KH, Antoniv T, Hu X, Ivashkiv LB. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol. 2008;9(4):378–87.

    Article  CAS  Google Scholar 

  12. Osher E, Macaulay VM. Therapeutic Targeting of the IGF Axis. Cells. 2019;8(8):895.

    Article  CAS  Google Scholar 

  13. Hakuno F, Takahashi SI. IGF1 receptor signaling pathways. J Mol Endocrinol. 2018;61(1):T69-t86.

    Article  CAS  Google Scholar 

  14. Zhang D, Samani AA, Brodt P. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res. 2003;35(11–12):802–8.

    CAS  Google Scholar 

  15. Brodt P, Fallavollita L, Khatib AM, Samani AA, Zhang D. Cooperative regulation of the invasive and metastatic phenotypes by different domains of the type I insulin-like growth factor receptor beta subunit. J Biol Chem. 2001;276(36):33608–15.

    Article  CAS  Google Scholar 

  16. Lianyungang: Clinical Significance of Changes of Serum VEGF,IGF-I Levels in Patients with Breast Cancer. Radioimmunology 2010.

  17. LeRoith D, Raizada M. Proceedings of the 4th International Symposium on Insulin, IGFs, and their Receptors. Woods Hole, Massachusetts, April 20–23, 1993. Adv Exp Med Biol. 1993;343:1–417.

    Google Scholar 

  18. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev. 1995;16(1):3–34.

    CAS  Google Scholar 

  19. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, Rosner B, Speizer FE, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet (London, England). 1998;351(9113):1393–6.

    Article  CAS  Google Scholar 

  20. Bruning PF, Van Doorn J, Bonfrèr JM, Van Noord PA, Korse CM, Linders TC, Hart AA. Insulin-like growth-factor-binding protein 3 is decreased in early-stage operable pre-menopausal breast cancer. Int J Cancer. 1995;62(3):266–70.

    Article  CAS  Google Scholar 

  21. Sarkissyan M, Mishra DK, Wu Y, Shang X, Sarkissyan S, Vadgama JV. IGF gene polymorphisms and breast cancer in African-American and Hispanic women. Int J Oncol. 2011;38(6):1663–73.

    CAS  Google Scholar 

  22. Saligan LN, Olson K, Filler K, Larkin D, Cramp F, Yennurajalingam S, Escalante CP, del Giglio A, Kober KM, Kamath J, et al. The biology of cancer-related fatigue: a review of the literature. Support Care Cancer. 2015;23(8):2461–78.

    Article  Google Scholar 

  23. Khosravi N, Stoner L, Farajivafa V, Hanson ED. Exercise training, circulating cytokine levels and immune function in cancer survivors: A meta-analysis. Brain Behav Immun. 2019;81:92–104.

    Article  CAS  Google Scholar 

  24. Mills RC 3rd. Breast Cancer Survivors, Common Markers of Inflammation, and Exercise: a Narrative Review. Breast cancer. 2017;11:1178223417743976.

    Google Scholar 

  25. Bruunsgaard H. Physical activity and modulation of systemic low-level inflammation. J Leukoc Biol. 2005;78(4):819–35.

    Article  CAS  Google Scholar 

  26. Orlandella FM, De Stefano AE, Iervolino PLC, Buono P, Soricelli A, Salvatore G. Dissecting the molecular pathways involved in the effects of physical activity on breast cancers cells: A narrative review. Life Sci. 2021;265:118790.

    Article  CAS  Google Scholar 

  27. Majorczyk M, Smoląg D. Effect of physical activity on IGF-1 and IGFBP levels in the context of civilization diseases prevention. Rocz Panstw Zakl Hig. 2016;67(2):105–11.

    CAS  Google Scholar 

  28. de Boer MC, Wörner EA, Verlaan D, van Leeuwen PAM. The Mechanisms and Effects of Physical Activity on Breast Cancer. Clin Breast Cancer. 2017;17(4):272–8.

    Article  Google Scholar 

  29. Schmid D, Leitzmann MF. Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis. Ann Oncol. 2014;25(7):1293–311.

    Article  CAS  Google Scholar 

  30. Bouillet T, Bigard X, Brami C, Chouahnia K, Copel L, Dauchy S, Delcambre C, Descotes JM, Joly F, Lepeu G, et al. Role of physical activity and sport in oncology: scientific commission of the National Federation Sport and Cancer CAMI. Crit Rev Oncol Hematol. 2015;94(1):74–86.

    Article  CAS  Google Scholar 

  31. Lahart IM, Metsios GS, Nevill AM, Carmichael AR. Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies. Acta oncologica (Stockholm, Sweden). 2015;54(5):635–54.

    Article  Google Scholar 

  32. Lugo D, Pulido AL, Mihos CG, Issa O, Cusnir M, Horvath SA, Lin J, Santana O. The effects of physical activity on cancer prevention, treatment and prognosis: a review of the literature. Complement Ther Med. 2019;44:9–13.

    Article  Google Scholar 

  33. Sprod LK, Janelsins MC, Palesh OG, Carroll JK, Heckler CE, Peppone LJ, Mohile SG, Morrow GR, Mustian KM. Health-related quality of life and biomarkers in breast cancer survivors participating in tai chi chuan. Cancer Surviv. 2012;6(2):146–54.

    Article  Google Scholar 

  34. Kang XY, Xu QY, Yu Z, Han SF, Zhu YF, Lv X. The effects of physical activity on physiological markers in breast cancer survivors: A meta-analysis. Medicine. 2020;99(20):e20231.

    Article  CAS  Google Scholar 

  35. Meneses-Echávez JF, Correa-Bautista JE, González-Jiménez E, Schmidt Río-Valle J, Elkins MR, Lobelo F, Ramírez-Vélez R. The Effect of Exercise Training on Mediators of Inflammation in Breast Cancer Survivors: a Systematic Review with Meta-analysis. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1009–17.

    Article  Google Scholar 

  36. Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. CA Cancer J Clin. 2016;66(1):43–73.

    Article  Google Scholar 

  37. McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55–61.

    Article  Google Scholar 

  38. Karimi N, Dabidi Roshan V, Fathi Bayatiyani Z. Individually and Combined Water-Based Exercise With Ginger Supplement, on Systemic Inflammation and Metabolic Syndrome Indices, Among the Obese Women With Breast Neoplasms. Iran J Cancer Prev. 2015;8(6):e3856.

    Article  Google Scholar 

  39. da Costa BR, Nüesch E, Rutjes AW, Johnston BC, Reichenbach S, Trelle S, Guyatt GH, Jüni P. Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study. J Clin Epidemiol. 2013;66(8):847–55.

    Article  Google Scholar 

  40. Hiensch AE, Mijwel S, Bargiela D, Wengström Y, May AM, Rundqvist H. Inflammation Mediates Exercise Effects on Fatigue in Patients with Breast Cancer. Med Sci Sports Exerc. 2021;53(3):496–504.

    Article  CAS  Google Scholar 

  41. Gómez AM, Martínez C, Fiuza-Luces C, Herrero F, Pérez M, Madero L, Ruiz JR, Lucia A, Ramírez M. Exercise training and cytokines in breast cancer survivors. Int J Sports Med. 2011;32(6):461–7.

    Article  Google Scholar 

  42. Jones SB, Thomas GA, Hesselsweet SD, Alvarez-Reeves M, Yu H, Irwin ML. Effect of exercise on markers of inflammation in breast cancer survivors: the Yale exercise and survivorship study. Cancer Prev Res (Phila). 2013;6(2):109–18.

    Article  CAS  Google Scholar 

  43. Rogers LQ, Fogleman A, Trammell R, Hopkins-Price P, Vicari S, Rao K, Edson B, Verhulst S, Courneya KS, Hoelzer K. Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial. Integr Cancer Ther. 2013;12(4):323–35.

    Article  CAS  Google Scholar 

  44. Bower JE, Greendale G, Crosswell AD, Garet D, Sternlieb B, Ganz PA, Irwin MR, Olmstead R, Arevalo J, Cole SW. Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial. Psychoneuroendocrinology. 2014;43:20–9.

    Article  CAS  Google Scholar 

  45. Dieli-Conwright CM, Courneya KS, Demark-Wahnefried W, Sami N, Lee K, Buchanan TA, Spicer DV, Tripathy D, Bernstein L, Mortimer JE. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial. J Clin Oncol. 2018;36(9):875–83.

    Article  CAS  Google Scholar 

  46. Dieli-Conwright CM, Parmentier JH, Sami N, Lee K, Spicer D, Mack WJ, Sattler F, Mittelman SD. Adipose tissue inflammation in breast cancer survivors: effects of a 16-week combined aerobic and resistance exercise training intervention. Breast Cancer Res Treat. 2018;168(1):147–57.

    Article  Google Scholar 

  47. Kim SH, Song YK, Han J, Ko YH, Lee H, Kang MJ, Park H, Lee H, Kim S. Erratum: Pro-inflammatory Cytokine Levels and Cancer-related Fatigue in Breast Cancer Survivors: Effects of an Exercise Adherence Program. J Breast Cancer. 2020;23(5):574–5.

    Article  Google Scholar 

  48. Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, Dipietro L, Mayne ST, Yu H. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: the Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev. 2009;18(1):306–13.

    Article  CAS  Google Scholar 

  49. Kang DW, Lee J, Suh SH, Ligibel J, Courneya KS, Jeon JY. Effects of Exercise on Insulin, IGF Axis, Adipocytokines, and Inflammatory Markers in Breast Cancer Survivors: A Systematic Review and Meta-analysis. Cancer Epidemio Biomarkers Prev. 2017;26(3):355–65.

    Article  CAS  Google Scholar 

  50. Han JK, Kim G. Role of physical exercise in modulating the insulin-like growth factor system for improving breast cancer outcomes: A meta-analysis. Exp Gerontol. 2021;152:111435.

    Article  CAS  Google Scholar 

  51. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74.

    Article  CAS  Google Scholar 

  52. Monteiro-Junior RS, de Tarso M-P. da Matta Mello Portugal E, da Silva Figueiredo LF, Terra R, Carneiro LSF, Rodrigues VD, Nascimento OJM, Deslandes AC, Laks J: Effect of Exercise on Inflammatory Profile of Older Persons: Systematic Review and Meta-Analyses. J Phys Act Health. 2018;15(1):64–71.

    Article  Google Scholar 

  53. De Luca V, Minganti C, Borrione P, Grazioli E, Cerulli C, Guerra E, Bonifacino A, Parisi A. Effects of concurrent aerobic and strength training on breast cancer survivors: a pilot study. Public Health. 2016;136:126–32.

    Article  Google Scholar 

  54. Hiraoui M, Al-Haddabi B, Gmada N, Doutrellot PL, Mezlini A, Ahmaidi S. Effects of combined supervised intermittent aerobic, muscle strength and home-based walking training programs on cardiorespiratory responses in women with breast cancer. Bull Cancer. 2019;106(6):527–37.

    Article  Google Scholar 

  55. Macaulay VM. Insulin-like growth factors and cancer. Br J Cancer. 1992;65(3):311–20.

    Article  CAS  Google Scholar 

  56. Karey KP, Sirbasku DA. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol. Can Res. 1988;48(14):4083–92.

    CAS  Google Scholar 

  57. Devin JL, Bolam KA, Jenkins DG, Skinner TL. The Influence of Exercise on the Insulin-like Growth Factor Axis in Oncology: Physiological Basis, Current, and Future Perspectives. Cancer Epidemiol Biomarkers Prev. 2016;25(2):239–49.

    Article  CAS  Google Scholar 

  58. Santa Mina D, Connor MK, Alibhai SM, Toren P, Guglietti C, Matthew AG, Trachtenberg J, Ritvo P. Exercise effects on adipokines and the IGF axis in men with prostate cancer treated with androgen deprivation: A randomized study. Canadian Urol Assoc J. 2013;7(11–12):E692-698.

    Article  Google Scholar 

Download references

Acknowledgements

None.

Funding

This work was supported by no funding.

Author information

Authors and Affiliations

  1. College of Physical Education, Shandong Normal University, Jinan, 250014, China

    Yanan Zhou, Ningxin Jia & Meng Ding

  2. Department of General Surgery, The First Affiliated Hospital of Shandong First Medical University, Jinan, 262799, Shandong, China

    Kai Yuan

Authors
  1. Yanan Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ningxin Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meng Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kai Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

YZ and MD planned the structure of the manuscript. YZ and NJ analyzed the data.YZ wrote the manuscript and designed the figures. KY revised and adjusted the overall content of the article, and helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kai Yuan.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhou, Y., Jia, N., Ding, M. et al. Effects of exercise on inflammatory factors and IGF system in breast cancer survivors: a meta-analysis. BMC Women's Health 22, 507 (2022). https://doi.org/10.1186/s12905-022-02058-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-022-02058-5

Keywords

BMC Women's Health

ISSN: 1472-6874

Contact us